Application 203822
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RISEDRONATE SODIUM | RISEDRONATE SODIUM | TABLET, DELAYED RELEASE;ORAL | 35MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203822-001 | RISEDRONATE SODIUM | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE / ORAL | 2018-09-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A203822-001 | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE / ORAL | 2018-09-11 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A203822-001 | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE / ORAL | 2018-09-11 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A203822-001 | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE / ORAL | 2018-09-11 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203822-001 | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE / ORAL | 2018-09-11 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Risedronate Sodium | RISEDRONATE SODIUM | Teva Pharmaceuticals USA, Inc. | dddcd321-4d2e-4643-bf3c-7b752b33ba39 | 2026-03-30 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Apotex Corp. | b90f2e5b-10b8-29a7-0360-31bd0dae0ec2 | 2026-03-02 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Macleods Pharmaceuticals Limited | 62aff8d6-a2f7-4c7e-a102-c70105ac3792 | 2026-03-01 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| risedronate sodium | RISEDRONATE SODIUM | Sun Pharmaceutical Industries, Inc. | e0b5f0ed-ff40-4f0d-bb86-81a7ace9f339 | 2026-02-17 | Warnings, Adverse reactions | risedronate sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Mylan Pharmaceuticals, Inc. | f715718a-407d-4e2a-9834-74a8f1361d03 | 2026-02-12 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Aurobindo Pharma Limited | 89896dfe-f69d-4cb3-bb71-7a7c611071fa | 2026-02-11 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Aurobindo Pharma Limited | a42a35e6-3e08-4b4f-ae56-47d4aec2322a | 2026-02-10 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Actonel | RISEDRONATE SODIUM | Allergan, Inc. | 24ed00e0-25e2-49a8-97fc-66c1b417dc0b | 2026-02-04 | Warnings, Adverse reactions | RISEDRONATE SODIUM |
| Atelvia | RISEDRONATE SODIUM | Allergan, Inc. | c8b9ab88-1a26-46c3-80ec-4eaa45202021 | 2026-02-03 | Warnings, Adverse reactions | RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Mylan Pharmaceuticals, Inc. | c89430be-15f1-4b8b-ab7e-738de716ee7d | 2026-02-03 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd | d60a56cb-ef49-4447-9043-7b6879a20d75 | 2025-12-16 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| Risedronate Sodium | RISEDRONATE SODIUM | Proficient Rx LP | 81702f21-3117-49ce-8e9b-2aa2648ba7c3 | 2022-11-01 | Warnings, Adverse reactions | Risedronate Sodium RISEDRONATE SODIUM |
| RISEDRONATE SODIUM | RISEDRONATE SODIUM | Sun Pharmaceutical Industires Inc. | 1d9e520b-2fa6-4603-b397-f0fc24fae775 | 2020-09-09 | Warnings, Adverse reactions | RISEDRONATE SODIUM RISEDRONATE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68382-075 | Risedronate Sodium | Risedronate Sodium | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-075 | Risedronate Sodium | Risedronate Sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-075 | Risedronate Sodium | Risedronate Sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-075 | Risedronate Sodium | Risedronate Sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70771-1436 | Risedronate Sodium | Risedronate Sodium | Cadila Healthcare Limited | ANDA | Current |
| 70771-1436 | Risedronate Sodium | Risedronate Sodium | Cadila Healthcare Limited | ANDA | Current |
| 70771-1436 | Risedronate Sodium | Risedronate Sodium | Cadila Healthcare Limited | ANDA | Current |
| 70771-1436 | Risedronate Sodium | Risedronate Sodium | Zydus Lifesciences Limited | ANDA | Current |